Active Ingredient History

NOW
  • Now
Sertindole, sold under the brand name Serdolect among others, is an antipsychotic medication. Sertindole was developed by the Danish pharmaceutical company Lundbeck and marketed under license by Abbott Labs. Like other atypical antipsychotics, it has activity at dopamine and serotonin receptors in the brain. It is used in the treatment of schizophrenia. It is classified chemically as a phenylindole derivative.   Wikipedia

  • SMILES: Fc1ccc(cc1)n2cc(C3CCN(CCN4CCNC4=O)CC3)c5cc(Cl)ccc25
  • InChIKey: GZKLJWGUPQBVJQ-UHFFFAOYSA-N
  • Mol. Mass: 440.95
  • ALogP: 4.63
  • ChEMBL Molecule:
More Chemistry
1-(2-(4-(5-chloro-1-(4-fluorophenyl)-1h-indol-3-yl)-1-piperidinyl)ethyl)-2-imidazolidinone | 1-[2-[4-[5-chloro-1-(4-fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one | lu 23-174 | lu-23-174 | serdolect | serlect | sertindol | sertindole | sertindole hcl | sertindole hydrochloride | sertindolum | zerdol

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue